Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
34 studies found for:    yohimbine
Show Display Options
Rank Status Study
1 Completed
Has Results
Randomized Study of Yohimbine Treatment for Type 2 Diabetes Patients Carrying a Specific Genetic Risk Variant
Condition: Type 2 Diabetes
Intervention: Drug: Yohimbine
2 Completed Bioequivalence Study Comparing Two Test Products With One Reference Product, All Containing 5 mg Yohimbine
Condition: Erectile Dysfunction
Intervention: Drug: Yohimbine
3 Completed
Has Results
Rapid Antidepressant Effects of Yohimbine in Major Depression
Conditions: Depression, Involutional;   Major Depresssion
Interventions: Drug: Yohimbine hydrochloride;   Drug: Placebo
4 Completed
Has Results
Yohimbine to Enhance Cognitive Behavioral Therapy (CBT) for Social Anxiety
Condition: Social Anxiety Disorder
Interventions: Behavioral: Group Cognitive Behavioral Therapy;   Drug: Yohimbine Hydrochloride;   Drug: Sugar Pill
5 Completed Facilitation of Fear Extinction With Yohimbine Hydrochloride in Phobic Participants
Condition: Phobic Disorders
Intervention: Behavioral: Virtual Reality Exposure Therapy
6 Completed Effect of Yohimbine on Colon Transit
Condition: Healthy Volunteers
Intervention: Drug: Yohimbine, oral
7 Completed
Has Results
Prolonged Exposure for Post Traumatic Stress Disorder (PTSD) With/Without Yohimbine
Condition: Post-Traumatic Stress Disorder
Interventions: Drug: Yohimbine;   Drug: Placebo
8 Completed The Effect of an α2-Adrenoceptor Antagonist (Yohimbine) on Dynamic Autoregulation in the Human Middle Cerebral Artery and Ophthalmic Artery
Conditions: Blood Flow Velocity;   Autoregulation;   Ocular Physiology
Intervention: Drug: Yohimbine hydrochloride
9 Completed Effects of Yohimbine and Naltrexone on Sexual Function
Condition: Erectile Dysfunction
Intervention: Drug: Naltrexone HCL/ Yohimbine HCL
10 Completed The Effect of Yohimbine on Cocaine Cue Reactivity
Condition: Cocaine Related Disorders
Interventions: Drug: Yohimbine;   Drug: Placebo
11 Completed Studies of Opioid Seeking Behavior: Yohimbine and Hydrocortisone Effects
Conditions: Heroin Dependence;   Opioid-Related Disorders
Intervention:
12 Not yet recruiting Effects of Melatonin to Reduce Nocturnal Hypertension in Patients With Neurogenic Orthostatic Hypotension
Conditions: Hypotension, Orthostatic;   Hypertension;   Autonomic Nervous System Diseases
Interventions: Drug: Yohimbine;   Drug: Melatonin
13 Completed
Has Results
Modulation of Pharmacologically Induced Alcohol Craving in Recently Detoxified Alcoholics
Condition: Alcoholism
Interventions: Drug: Acamprosate;   Drug: Yohimbine;   Drug: mCPP;   Drug: Saline
14 Recruiting Common Noradrenergic Mechanisms in Parkinson´s Disease and L-DOPA Induced Dyskinesia
Condition: Parkinson´s Disease
Intervention: Drug: L-DOPA
15 Completed Effects of Stress Hormones on Emotion and Cognition
Condition: Healthy
Intervention: Drug: Yohimbine
16 Completed Brain Receptors in Sympathetic Nervous System Regulation
Condition: Healthy
Intervention: Drug: Yohimbine
17 Recruiting Noradrenergic Activity, Cognition and Major Depressive Disorder
Conditions: Major Depressive Disorder;   Early Life Trauma
Interventions: Drug: yohimbine;   Drug: placebo
18 Unknown  The Role of Sympatho-vagal Balance on Different Limbs of Pain Perception in Healthy Subjects
Condition: Pain
Intervention: Drug: Yohimbine
19 Completed Noradrenergic Manipulation and Virtual Reality Exposure Therapy in Phobic Participants
Condition: Phobic Disorders
Intervention: Behavioral: Virtual Reality Exposure Therapy (VRET)
20 Completed
Has Results
Iloprost Power 15 in Pulmonary Arterial Hypertension
Condition: Pulmonary Arterial Hypertension
Interventions: Drug: iloprost (5 µg);   Drug: placebo

   Previous Page Studies Shown (1-20) Next Page (21-34) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.